Homberg leads Raupach’s novel Life Sciences Team
Frankfurt – Raupach & Wollert-Elmendorff is expanding into the life sciences sector. In January, the respected German advisors for business law announced they had hired Peter Homberg as an Equity Partner. Homberg is a renowned expert for life sciences and intellectual property (IP). The specialist for transactions will head up the firm’s office in Frankfurt, which will especially address the needs of companies from the life sciences sector.
Homberg is arriving from Raupach’s competitor Jones Day, where he led the European Life Sciences team. He has a long track record in counseling companies from the pharma, biotech, diagnostics and medical devices branches. His colleague Andrea Veh has also moved to Raupach, and will work as an Associate in the new team.
“For our Frankfurt office, Peter Homberg gives an important growth impulse,” said Martin Imbeck, Managing Partner at Raupach. Homberg said he is looking forward to establishing a new life sciences practice at the top-50 German-based law firm.
Up to now, Raupach has only provided counsel to firms in medical law. Homberg brings in additional expertise to accompany international financing rounds, M&As, licensing and patent deals – “From start-ups to large enterprises,” he says.
Homberg told EuroBiotechNews that he expects to quickly expand the new Life Sciences team. One possibility would be to admit additional patent attorneys.
Raupach ranks among the 50 largest German law firms, with more than 90 attorneys in seven offices throughout Germany, and an international network of partners. The company is a strategic partner of Deloitte, one of the leading international audit and consulting firms.
Before taking over his function at Jones Day, Homberg was Deputy General Counsel at Roche Diagnostics (formerly Boehringer Mannheim). Previously, he worked as Head of Equity Projects at a Daimler subsidiary, and also headed the Singapore office of Thümmel, Schütze & Partners. In 2000, Homberg joined Jones Day’s Frankfurt office, and from 2003 on he established Jones Day’s life sciences and IP practice in Munich.